Skip to main content

Paul Alfred Gurbel

Adjunct Professor in the Department of Medicine
Medicine, Clinical Pharmacology

Current Appointments & Affiliations


Adjunct Professor in the Department of Medicine · 2013 - Present Medicine, Clinical Pharmacology, Medicine

Recent Publications


Residual Cardiovascular Biomarkers After Medical Therapy and Their Prognostic Implications Following Percutaneous Coronary Intervention

Journal Article Jacc Advances · February 1, 2026 Background: Despite medical therapy, atherothrombotic events remain common in high-risk patients with coronary artery disease. Objectives: The purpose of this study was to evaluate the association between atherothrombotic biomarkers and outcomes in patient ... Full text Cite

TEG ® 6s Heparin Neutralization Cartridge for Hemostatic Assessment of Patients Undergoing Cardiovascular Surgery.

Journal Article Anesthesiology · January 1, 2026 BACKGROUND: Heparin administration can limit viscoelastic testing. The cartridge-based TEG ® 6s thromboelastography system (Haemonetics Corp., USA) uses heparinase to neutralize heparin effects. This study aimed to validate the TEG 6s global hemostasis-hep ... Full text Link to item Cite

Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

Journal Article Crit Care · December 28, 2025 BACKGROUND: Evidence for cangrelor in critically ill patients remains extremely limited, despite heightened thrombotic risk from delayed oral P2Y12 inhibitor effects post- percutaneous coronary intervention (PCI). We aim to assess intravenous (IV) cangrelo ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


University of Maryland, Baltimore · 1983 M.D.